NCT06956690
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06956690
Title A Phase 1/2 Clinical Trial to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HMBD-501 in Patients With HER3-Expressing Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Hummingbird Bioscience
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | AUS

Facility Status City State Zip Country Details
Research Site RECRUITING La Jolla California 92093 United States Details
Research Site RECRUITING Indianapolis Indiana 46250 United States Details
Research Site RECRUITING Farmington Hills Michigan 48334 United States Details
Research Site RECRUITING Dallas Texas 75230 United States Details
Research Site RECRUITING Campbelltown New South Wales 2560 Australia Details
Research Site RECRUITING Miranda New South Wales 2228 Australia Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field